Question 1

Does Connor, Clark & Lunn Investment Management own VIVO stock?

Accepted Answer

No. Connor, Clark & Lunn Investment Management exited its VIVO (Meridian Bioscience) position in Q3 2020. Its Q2 2020 13F listed 15,571 shares worth $363,000.

Question 2

How many shares of VIVO does Connor, Clark & Lunn Investment Management own?

Accepted Answer

None since Q3 2020, when Connor, Clark & Lunn Investment Management exited the position. Its Q2 2020 13F listed 15,571 shares worth $363,000.

Question 3

What is Connor, Clark & Lunn Investment Management's VIVO position worth?

Accepted Answer

Connor, Clark & Lunn Investment Management's VIVO position was worth $363,000 in its Q2 2020 13F, before the exit in Q3 2020.

Question 4

Is Connor, Clark & Lunn Investment Management buying or selling VIVO?

Accepted Answer

In Q3 2020, Connor, Clark & Lunn Investment Management exited its entire VIVO position.

Question 5

When did Connor, Clark & Lunn Investment Management first buy VIVO?

Accepted Answer

Connor, Clark & Lunn Investment Management already held VIVO in its Q4 2018 13F, the earliest on record, and listed it in 6 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2020-Q3 Latest	Exited	0	-100.0%	$0	0.0%	$91.60	0
2020-Q2	Decreased	15,571	-84.9%	$363,000	0.0%	$13.20	0
2020-Q1	Increased	102,900	+54.3%	$864,000	0.0%	$7.40	35
2019-Q4	Decreased	66,700	-36.6%	$652,000	0.0%	$10.50	0
2019-Q3	Increased	105,275	+27.6%	$999,000	0.0%	$13.03	31
2019-Q2	New	82,525	-	$980,000	0.0%	$14.00	35
2019-Q1	Exited	0	-100.0%	$0	0.0%	$12.80	0
2018-Q4	First report	22,850	-	$397,000	0.0%	$6.45	0